2008
DOI: 10.1007/s12094-008-0162-4
|View full text |Cite
|
Sign up to set email alerts
|

Centralised treatment of soft tissue sarcomas in adults

Abstract: The clinical research developed in specialised centres and oncologic cooperative groups has permitted various scientific societies to collect recommendations used in the treatment of soft tissue sarcomas (STS) and incorporate them into clinical practice guidelines (CPG). Some studies have been conducted in diverse healthcare ambits to assess the influence of CPG. This revision of the medical literature analyses the impact that healthcare management -centralised or otherwise- and clinical practice in conformity… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 51 publications
0
3
0
Order By: Relevance
“…Obviously, the significant positive role of a Referral Center led by a high level of multidisciplinary expertise has been proved to have a cost-effectiveness impact on the management of rare cancers and could potentially impact the value of the diagnostic delay on survival. [19][20][21][22] We reported a significantly worse 5-year OS in the youngest cohort (≤25 years old), which represents almost 30% of patients in our sample and harbors the highest incidence of SRCT, mostly extraskeletal Ewing's sarcomas and desmoplastic small round cell tumor. The prevalence of these histologies could explain the poorer OS, given that these tumors are typically diagnosed in pediatric patients, but in AYA patients are characterized by a worse clinical outcome, compared with pediatric patients.…”
Section: Discussionmentioning
confidence: 59%
See 1 more Smart Citation
“…Obviously, the significant positive role of a Referral Center led by a high level of multidisciplinary expertise has been proved to have a cost-effectiveness impact on the management of rare cancers and could potentially impact the value of the diagnostic delay on survival. [19][20][21][22] We reported a significantly worse 5-year OS in the youngest cohort (≤25 years old), which represents almost 30% of patients in our sample and harbors the highest incidence of SRCT, mostly extraskeletal Ewing's sarcomas and desmoplastic small round cell tumor. The prevalence of these histologies could explain the poorer OS, given that these tumors are typically diagnosed in pediatric patients, but in AYA patients are characterized by a worse clinical outcome, compared with pediatric patients.…”
Section: Discussionmentioning
confidence: 59%
“…Obviously, the significant positive role of a Referral Center led by a high level of multidisciplinary expertise has been proved to have a cost‐effectiveness impact on the management of rare cancers and could potentially impact the value of the diagnostic delay on survival. 19 , 20 , 21 , 22 …”
Section: Discussionmentioning
confidence: 99%
“…Recently, a population-based study reported in patients undergoing limb-sparing surgery for STS of the extremities concluded that radiotherapy was associated with improved survival in patients with highgrade tumour [44]. Adjuvant radiotherapy is employed together with surgery in the case of STS showing a poor prognosis (T2, G2-3) after surgery with close (<10 mm) or microscopically affected margins and after surgery of locally relapsed previously untreated STS [5, 6, 45,46].…”
Section: Radiotherapymentioning
confidence: 99%